Search results
Third Rock’s Marea ropes in $190M to pioneer ‘the next frontier’ of cardiometabolic medicines
FierceBiotech· 7 days agoPreclinical models found that MAR001 reduced triglycerides, remnant cholesterol and ectopic fat,...
FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities
Clinical Trials Arena via Yahoo Finance· 6 days agoTo address the FDA... Growth Factor Receptor 3 (HER3). Other big pharma companies including Pfizer,...
Izokibep Enthesitis Benefit Lacking in Phase 2b/3 PsA Trial
Medscape· 6 days agoThe primary efficacy endpoint was met, but the novel small molecule therapeutic did not reduce...
The Most Populated Country in the World
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 50 Most Populated Countries in the World and in this article, we will look at the most populated country in the world...
Zealand lines up Novo challenger as backbone weight loss therapy after phase 1 data
FierceBiotech· 4 days agoZealand Pharma is lining up a challenge to its compatriot Novo Nordisk. The Danish biotech’s CEO said obesity candidate petrelintide can be “the backbone of therapy for weight management” after ...
Gateway - The Root
The Root· 7 days agoRev. Jesse Jackson and his wife, Jacqueline, were admitted to Northwestern Memorial Hospital in Chicago according to a statement from his organization Rainbow PUSH Coalition (RPC) on Saturday ...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 6 days agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
Gateway - Quartz
Quartz· 7 days agoAs of the end of 2022, about a quarter of the population of African countries has been fully vaccinated against covid-19, according to the latest figures shared by Africa CDC. Congo, Sudan, ...
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 7 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...
Biotech startup raises $190 million to focus on new approach to heart attack, stroke and more - San...
The Business Journals· 7 days agoA serial biotech entrepreneur, a longtime UCSF researcher, a shelved Big Pharma drug and $190...
